Idarubicin (4-demethoxydaunorubicin)

Abstract

4-Demethoxydaunorubicin (4-DMDR, IMI 30, Idarubicin, NSC 256439) is a new analog of daunorubicin (DNR) with antileukemic activity in experimental systems that is superior to that of daunorubicin (DNR) or doxorubicin (DX). The drug is more potent than DNR and DX and is active by both the intravenous and the oral routes of administration. After i.v. and oral… (More)
DOI: 10.1007/BF00172021

Topics

12 Figures and Tables

Slides referencing similar topics